Next, we quantified subsets of APCs in the tumour microenvironment: CD14+ monocyte/macrophage-like cells, CD11c+CD141+ cross-presenting type 1 classical dendritic cells (cDC1s), CD11c+CD1c+CD163− cDC2s, CD11c+CD1c+CD163+ DC3s (previously referred to as inflammatory dendritic cells24–26) and CD16+ non-conventional monocytes (Fig. 1e, Extended Data Fig. 1i). This evidence concerns the gene CD163 and neoplasm.